ADAMANTYL-THPINACA

ADAMANTYL-THPINACA

Systematic (IUPAC) name
N-(2-adamantyl)-1-(tetrahydropyran-4-ylmethyl)indazole-3-carboxamide
Clinical data
Legal status	CA: Schedule II
Identifiers
CAS Number	1400742-48-4
Chemical data
Formula	C24H31N3O2
Molar mass	393.53 g/mol
SMILES C12C(C3CC(CC(C1)C3)C2)NC(=O)C2=NN(C3=CC=CC=C23)CC2CCOCC2
InChI InChI=1/C24H31N3O2/c28-24(25-22-18-10-16-9-17(12-18)13-19(22)11-16)23-20-3-1-2-4-21(20)27(26-23)14-15-5-7-29-8-6-15/h1-4,15-19,22H,5-14H2,(H,25,28)/f/h25H Key:XFZLBNDGZVRJNJ-UHFFFAOYSA-N

ADAMANTYL-THPINACA is an indazole-based synthetic cannabinoid that is presumed to be a potent agonist of the CB₁ receptor and has been sold online as a designer drug. It was first discovered in Slovenia as part of a seizure of 746 grams of white powder and 2 kilograms of brown/green plant material in October 2014.^[1]

Legal status

ADAMANTYL-THPINACA is banned in Sweden.^[2]

See also

• 5F-ADB
• 5F-AMB
• 5F-APICA
• AB-CHMINACA
• AB-FUBINACA
• AB-CHFUPYCA
• AB-PINACA
• ADB-CHMINACA
• ADB-FUBINACA
• ADB-PINACA
• APICA
• APINACA
• APP-FUBINACA
• CUMYL-THPINACA
• MDMB-CHMINACA
• MDMB-FUBINACA
• PX-3

References

1. "Muuntohuumeiden esiintyvyys 2015" (PDF). Finnish Medicines Agency. 7 May 2015. Retrieved 24 July 2015.
2. "Fler ämnen föreslås bli klassade som narkotika eller hälsofarlig vara". Folkhälsomyndigheten. Retrieved 24 July 2015.